Fabino Enterprises Ltd

Fabino Enter Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fabino Enterprises Ltd

₹ 26.0 0.00%
08 Aug 2025
fabinolife.com BSE - SME: 543444
About

Incorporated in 2011, Fabino Enterprises manufactures, markets, trades, and does packing of pharmaceutical and other wellness focused consumer products[1]

Key Points

Business Overview:[1][2]
a) FEL is an ISO 9001:2015 pharmaceutical company located near the Delhi NCR region. It offers a wide range of allopathic and herbal products.
b) Company markets pharmaceutical formulation for domestic market and sells through own distribution network and sales force under
their own brand name
c) It gets Ayurvedic formulations manufactured through Loan Licensing facilities, Packing, Labelling etc.
d) Company exports wellness and FMCG products like Coffee, Malt powder, Protein powder, Hair shampoo which it also markets

Website BSE
  • Market Cap ₹ 5.46 Cr.
  • Current Price ₹ 26.0
  • High / Low ₹ 39.0 / 22.8
  • Stock P/E 42.0
  • Book Value ₹ 20.4
  • Dividend Yield 0.00 %
  • ROCE 7.16 %
  • ROE 3.08 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Debtor days have improved from 277 to 177 days.
  • Company's working capital requirements have reduced from 277 days to 103 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 1.52% over last 3 years.
  • Company has high debtors of 177 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Half Yearly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Sep 2021 Mar 2022 Sep 2022 Mar 2023 Sep 2023 Mar 2024 Sep 2024 Mar 2025
2.38 2.05 2.15 1.04 2.32 0.94 5.14 4.25 13.78
2.15 2.11 2.00 1.03 2.30 0.87 5.10 4.21 13.65
Operating Profit 0.23 -0.06 0.15 0.01 0.02 0.07 0.04 0.04 0.13
OPM % 9.66% -2.93% 6.98% 0.96% 0.86% 7.45% 0.78% 0.94% 0.94%
0.00 0.01 0.00 0.02 0.00 0.00 0.00 0.11 0.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.06 0.07
Depreciation 0.02 0.00 0.03 0.02 0.02 0.01 0.01 0.02 0.04
Profit before tax 0.21 -0.05 0.12 0.01 0.00 0.06 0.01 0.07 0.20
Tax % 0.00% 0.00% 16.67% 0.00% 33.33% 0.00% 28.57% 55.00%
0.21 -0.05 0.10 0.01 0.00 0.05 0.00 0.05 0.09
EPS in Rs 1.75 -0.42 0.48 0.05 0.00 0.24 0.00 0.24 0.43
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
2.76 7.52 3.06 4.19 3.36 6.01 18.00
2.44 7.20 2.99 4.09 3.33 5.90 17.83
Operating Profit 0.32 0.32 0.07 0.10 0.03 0.11 0.17
OPM % 11.59% 4.26% 2.29% 2.39% 0.89% 1.83% 0.94%
0.00 0.00 0.00 0.01 0.02 0.00 0.29
Interest 0.29 0.20 0.01 0.01 0.01 0.02 0.13
Depreciation 0.03 0.02 0.02 0.03 0.03 0.03 0.07
Profit before tax 0.00 0.10 0.04 0.07 0.01 0.06 0.26
Tax % 30.00% 25.00% 28.57% 0.00% 16.67% 50.00%
0.00 0.07 0.03 0.05 0.01 0.05 0.13
EPS in Rs 0.00 4.67 0.25 0.24 0.05 0.24 0.62
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years: %
5 Years: 19%
3 Years: 63%
TTM: 200%
Compounded Profit Growth
10 Years: %
5 Years: 13%
3 Years: 38%
TTM: 160%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: 2%
1 Year: -9%
Return on Equity
10 Years: %
5 Years: 2%
3 Years: 2%
Last Year: 3%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 0.15 0.15 1.20 2.10 2.10 2.10 2.10
Reserves 0.45 0.52 0.10 2.00 2.01 2.06 2.19
2.52 1.08 0.31 0.05 0.41 0.84 1.61
5.43 1.83 0.65 0.48 0.50 4.50 7.11
Total Liabilities 8.55 3.58 2.26 4.63 5.02 9.50 13.01
0.10 0.08 0.16 0.17 0.15 0.24 0.46
CWIP 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.00 0.00 0.00 0.00 0.00 0.05 0.05
8.45 3.50 2.10 4.46 4.87 9.21 12.50
Total Assets 8.55 3.58 2.26 4.63 5.02 9.50 13.01

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.18 2.44 -0.45 -1.90 -0.68 -0.46 -0.12
-0.01 0.00 -0.10 -0.05 -0.01 -0.18 -0.41
-0.18 -2.37 0.45 2.47 0.34 0.43 0.73
Net Cash Flow 0.00 0.07 -0.10 0.52 -0.35 -0.22 0.20

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 338.55 113.09 158.64 125.44 274.84 377.75 177.43
Inventory Days 988.71 15.36 62.61 174.83 147.24 88.59 26.56
Days Payable 1,024.81 77.34 63.94 34.76 45.78 294.40 152.06
Cash Conversion Cycle 302.45 51.11 157.31 265.51 376.29 171.94 51.93
Working Capital Days 19.84 51.93 165.80 292.70 444.30 282.40 103.21
ROCE % 12.32% 2.98% 2.78% 0.46% 1.68% 7.16%

Shareholding Pattern

Numbers in percentages

9 Recently
Mar 2022Sep 2022Mar 2023Sep 2023Mar 2024Sep 2024Mar 2025
56.82% 56.82% 56.82% 56.82% 56.82% 56.82% 56.82%
43.18% 43.19% 43.18% 43.18% 43.18% 43.18% 43.18%
No. of Shareholders 195168160151138138137

Documents

Announcements

Annual reports

DRHP